Screener
Fulgent Genetics, Inc. FLGT Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $21,125 | $18,654 |
| Accrued liabilities | 34,901 | 34,057 |
| Customer deposit | 30,619 | 28,145 |
| Contract liabilities | 3,007 | 3,635 |
| Notes payable, current | 482 | 476 |
| Total current liabilities | 90,134 | 84,967 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s accrued expenses?
- Fulgent Genetics, Inc. (FLGT) reported accrued expenses of $34.9M in Q1 2026.
- How has Fulgent Genetics, Inc.'s accrued expenses changed year-over-year?
- Fulgent Genetics, Inc.'s accrued expenses increased by 109.1% year-over-year, from $16.69M to $34.9M.
- What is the long-term trend for Fulgent Genetics, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s accrued expenses has grown at a 233.9% compound annual growth rate (CAGR), from $82K to $34.06M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Fulgent Genetics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude